Taken together, these findings suggest that let-7a acts as a novel suppressor by targeting the AKT2 gene and might be a candidate target for the development of novel therapeutic strategies to treat papillary thyroid carcinoma. The gene discussed is AKT2; the disease is thyroid gland papillary carcinoma.